Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: Research Roundup

Research Roundup: J&J releases interim vaccine data, African Union secures 270 million vaccine doses, and experts affirm need for next-generation vaccines
PATH/Matthew Dakin
January 19, 2021

Research Roundup: J&J releases interim vaccine data, African Union secures 270 million vaccine doses, and experts affirm need for next-generation vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation
PATH/Eric Becker
January 11, 2021

Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval
PATH/Rocky Prajapati
January 4, 2021

Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Moderna shot gets EUA, 2 monoclonal antibody treatments enter phase 3 trials, and first at-home, over-the-counter COVID-19 diagnostic gets EUA
PATH/Rocky Prajapati
December 21, 2020

Research Roundup: Moderna shot gets EUA, 2 monoclonal antibody treatments enter phase 3 trials, and first at-home, over-the-counter COVID-19 diagnostic gets EUA

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Pfizer shot gets EUA, vaccine inequity threatens global COVID-19 fight, and drug developers pursue COVID-19 therapeutics
PATH/Rocky Prajapati
December 14, 2020

Research Roundup: Pfizer shot gets EUA, vaccine inequity threatens global COVID-19 fight, and drug developers pursue COVID-19 therapeutics

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: UK approves Pfizer vaccine, the question of pregnant health care workers in vaccine distribution, and a quantitative antibody test
PATH/Aaron Joel Santos
December 7, 2020

Research Roundup: UK approves Pfizer vaccine, the question of pregnant health care workers in vaccine distribution, and a quantitative antibody test

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Moderna seeks vaccine EUA, COVID-19 drug trial launches, and equitable vaccine distribution efforts around the world
PATH/Aaron Joel Santos
November 30, 2020

Research Roundup: Moderna seeks vaccine EUA, COVID-19 drug trial launches, and equitable vaccine distribution efforts around the world

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Pfizer seeks vaccine EUA, AstraZeneca's phase 3 trial results, and first fully at-home COVID-19 diagnostic
PATH/Matthew Dakin
November 23, 2020

Research Roundup: Pfizer seeks vaccine EUA, AstraZeneca's phase 3 trial results, and first fully at-home COVID-19 diagnostic

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Promising Pfizer vaccine data, first COVID-19 antibody drug EUA, and a cheap diagnostic kit
PATH/Rose Slavkovsky
November 16, 2020

Research Roundup: Promising Pfizer vaccine data, first COVID-19 antibody drug EUA, and a cheap diagnostic kit

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: ACT Accelerator therapeutics priorities, COVID-19 vaccine agreements, and a potential nasal spray prevention method
PATH/Gabe Bienczycki
November 9, 2020

Research Roundup: ACT Accelerator therapeutics priorities, COVID-19 vaccine agreements, and a potential nasal spray prevention method

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Regeneron antibody trial updates, a breathalyzer diagnostic, and vaccines pledged to COVAX
PATH/Doune Porter
November 2, 2020

Research Roundup: Regeneron antibody trial updates, a breathalyzer diagnostic, and vaccines pledged to COVAX

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Upcoming COVID-19 vaccine data, a quantitative antibody diagnostic, and vaccine distribution preparation
PATH/Rocky Prajapati
October 26, 2020

Research Roundup: Upcoming COVID-19 vaccine data, a quantitative antibody diagnostic, and vaccine distribution preparation

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: COVID-19 clinical trials paused, Pfizer to expand vaccine trial to adolescents, and first Ebola treatment approved by FDA
PATH/Gabe Bienczycki
October 19, 2020

Research Roundup: COVID-19 clinical trials paused, Pfizer to expand vaccine trial to adolescents, and first Ebola treatment approved by FDA

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Moderna will not enforce COVID-19 patents, rolling EMA approval for vaccine candidates, and monoclonal antibody treatment study results
PATH/Nguyen Phu Cuong
October 12, 2020

Research Roundup: Moderna will not enforce COVID-19 patents, rolling EMA approval for vaccine candidates, and monoclonal antibody treatment study results

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: ACT Accelerator funding pledges, low-cost tests for LMICs, and early antibody cocktail trial results
PATH/Gabe Bienczycki
October 5, 2020

Research Roundup: ACT Accelerator funding pledges, low-cost tests for LMICs, and early antibody cocktail trial results

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: J&J starts phase 3 trials, a point-of-care COVID-19 antibody test, and global vaccine distribution
PATH/Doune Porter
September 28, 2020

Research Roundup: J&J starts phase 3 trials, a point-of-care COVID-19 antibody test, and global vaccine distribution

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: COVID-19 vaccine allocation plans, an at-home diagnostic, and positive results on a new treatment
PATH/Patrick McKern
September 21, 2020

Research Roundup: COVID-19 vaccine allocation plans, an at-home diagnostic, and positive results on a new treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: AstraZeneca's UK trial resumes, new rapid antigen test, and US will not join global vaccine initiative
PATH/Thet Htoo
September 14, 2020

Research Roundup: AstraZeneca's UK trial resumes, new rapid antigen test, and US will not join global vaccine initiative

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: COVID-19 steroid treatment studies, long-lasting antibodies, and NIH support for diagnostics
PATH/Patrick McKern
September 8, 2020

Research Roundup: COVID-19 steroid treatment studies, long-lasting antibodies, and NIH support for diagnostics

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: A simple, rapid COVID-19 diagnostic, a potential remdesivir-like treatment, and nasal spray vaccines
PATH/Gabe Bienczycki
August 31, 2020

Research Roundup: A simple, rapid COVID-19 diagnostic, a potential remdesivir-like treatment, and nasal spray vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.
Header Photo: PATH/Evelyn Hockstein

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In